Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Aging ; h5-index 49.0

This study aimed to develop a model that fused multiple features (multi-feature fusion model) for predicting metachronous distant metastasis (DM) in breast cancer (BC) based on clinicopathological characteristics and magnetic resonance imaging (MRI). A nomogram based on clinicopathological features (clinicopathological-feature model) and a nomogram based on the multi-feature fusion model were constructed based on BC patients with DM (n=67) and matched patients (n=134) without DM. DM was diagnosed on average (17.31±13.12) months after diagnosis. The clinicopathological-feature model included seven features: reproductive history, lymph node metastasis, estrogen receptor status, progesterone receptor status, CA153, CEA, and endocrine therapy. The multi-feature fusion model included the same features and an additional three MRI features (multiple masses, fat-saturated T2WI signal, and mass size). The multi-feature fusion model was relatively better at predicting DM. The sensitivity, specificity, diagnostic accuracy and AUC of the multi-feature fusion model were 0.746 (95% CI: 0.623-0.841), 0.806 (0.727-0.867), 0.786 (0.723-0.841), and 0.854 (0.798-0.911), respectively. Both internal and external validations suggested good generalizability of the multi-feature fusion model to the clinic. The incorporation of MRI factors significantly improved the specificity and sensitivity of the nomogram. The constructed multi-feature fusion nomogram may guide DM screening and the implementation of prophylactic treatment for BC.

Ma Wenjuan, Wang Xin, Xu Guijun, Liu Zheng, Yin Zhuming, Xu Yao, Wu Haixiao, Baklaushev Vladimir P, Peltzer Karl, Sun Henian, Kharchenko Natalia V, Qi Lisha, Mao Min, Li Yanbo, Liu Peifang, Chekhonin Vladimir P, Zhang Chao

2020-Sep-28

artificial intelligence, breast neoplasms, early detection, neoplasm metastasis